HP INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (In millions) | |||||||
Three months ended | |||||||
April 30, 2022 | April 30, 2021 | ||||||
Cash flows from operating activities: | |||||||
Net earnings | $ | 1,000 | $ | 1,228 | |||
Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||||
Depreciation and amortization | 193 | 186 | |||||
Stock-based compensation expense | 70 | 76 | |||||
Restructuring and other charges | 82 | 39 | |||||
Deferred taxes on earnings | (10 | ) | (17 | ) | |||
Other, net | 118 | 39 | |||||
Changes in operating assets and liabilities, net of acquisitions: | |||||||
Accounts receivable | (246 | ) | 258 | ||||
Inventory | 7 | (830 | ) | ||||
Accounts payable | (1,054 | ) | 235 | ||||
Net investment in leases | (21 | ) | (21 | ) | |||
Taxes on earnings | (17 | ) | (169 | ) | |||
Restructuring and other | (47 | ) | (46 | ) | |||
Other assets and liabilities | 433 | 468 | |||||
Net cash provided by operating activities | 508 | 1,446 | |||||
Cash flows from investing activities: | |||||||
Investment in property, plant and equipment | (178 | ) | (121 | ) | |||
Purchases of available-for-sale securities and other investments | (8 | ) | (12 | ) | |||
Maturities and sales of available-for-sale securities and other investments | 7 | — | |||||
Collateral posted for derivative instruments | — | (9 | ) | ||||
Payment made in connection with business acquisition, net of cash acquired | (3 | ) | (170 | ) | |||
Net cash used in investing activities | (182 | ) | (312 | ) | |||
Cash flows from financing activities: | |||||||
Proceeds from debt, net of issuance costs | 2,021 | 34 | |||||
Payment of debt | (46 | ) | (58 | ) | |||
Stock-based award activities and others | (5 | ) | 3 | ||||
Repurchase of common stock | (1,010 | ) | (1,610 | ) | |||
Cash dividends paid | (262 | ) | (239 | ) | |||
Settlement of cash flow hedges | 59 | — | |||||
Net cash provided by (used in) financing activities | 757 | (1,870 | ) | ||||
Increase (decrease) in cash and cash equivalents | 1,083 | (736 | ) | ||||
Cash and cash equivalents at beginning of period | 3,394 | 4,160 | |||||
Cash and cash equivalents at end of period
| $ | 4,477 | $ | 3,424 |